UK markets open in 12 minutes
NIKKEI 225
38,229.11 +155.13 (+0.41%) HANG SENG
18,932.68 +394.87 (+2.13%) CRUDE OIL
79.92 +0.66 (+0.83%) GOLD FUTURES
2,369.80 +29.50 (+1.26%) DOW
39,387.76 +331.36 (+0.85%) Bitcoin GBP
50,196.23 +1,111.60 (+2.26%)
Mirum Pharmaceuticals, Inc. (MIRM)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.22B |
| Enterprise value | 1.22B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 4.99 |
| Price/book (mrq) | 5.20 |
| Enterprise value/revenue | 5.47 |
| Enterprise value/EBITDA | -5.66 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.13 |
| 52-week change 3 | -0.81% |
| S&P500 52-week change 3 | 26.43% |
| 52-week high 3 | 35.56 |
| 52-week low 3 | 23.14 |
| 50-day moving average 3 | 25.93 |
| 200-day moving average 3 | 28.08 |
Share statistics
| Avg vol (3-month) 3 | 494.78k |
| Avg vol (10-day) 3 | 410.02k |
| Shares outstanding 5 | 47.13M |
| Implied shares outstanding 6 | 47.13M |
| Float 8 | 35.28M |
| % held by insiders 1 | 2.23% |
| % held by institutions 1 | 125.82% |
| Shares short (15 Apr 2024) 4 | 8.58M |
| Short ratio (15 Apr 2024) 4 | 14.47 |
| Short % of float (15 Apr 2024) 4 | 21.19% |
| Short % of shares outstanding (15 Apr 2024) 4 | 18.20% |
| Shares short (prior month 15 Mar 2024) 4 | 8.14M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -70.79% |
| Operating margin (ttm) | -38.24% |
Management effectiveness
| Return on assets (ttm) | -13.76% |
| Return on equity (ttm) | -84.40% |
Income statement
| Revenue (ttm) | 224M |
| Revenue per share (ttm) | 5.18 |
| Quarterly revenue growth (yoy) | 119.10% |
| Gross profit (ttm) | N/A |
| EBITDA | -93.32M |
| Net income avi to common (ttm) | -158.56M |
| Diluted EPS (ttm) | -3.74 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 302.84M |
| Total cash per share (mrq) | 6.43 |
| Total debt (mrq) | 307.52M |
| Total debt/equity (mrq) | 131.08% |
| Current ratio (mrq) | 3.68 |
| Book value per share (mrq) | 4.99 |
Cash flow statement
| Operating cash flow (ttm) | -36.96M |
| Levered free cash flow (ttm) | -15.42M |
© 2024 Yahoo. All rights reserved.